MedTrace Logo

Menthol, Inflammation, and Nicotine Transition Study

NCT06232447 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2026-04-16

No results posted yet for this study

Summary

This study will focus on examining the potential impact of menthol flavoring in cigarettes on biomarkers of systemic inflammation as a subclinical indicator of cardiovascular disease risk.

Conditions

  • Cigarette Smoking
  • Inflammatory Response

Interventions

OTHER

Cigarette Type Switching

Participants will be switched from smoking menthol cigarettes to non-menthol cigarettes for a period of four weeks

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Rosalind Franklin University of Medicine and Science

    lead OTHER

Principal Investigators

  • Nancy C Jao, PhD · Rosalind Franklin University of Medicine and Science

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-26
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06232447 on ClinicalTrials.gov